tiprankstipranks
Teva Pharmaceutical (DE:TEV)
FRANKFURT:TEV
Germany Market
TEV
Teva Pharmaceutical
RESEARCH TOOLSreports

Teva Pharmaceutical (TEV) Ratios

36 Followers

Teva Pharmaceutical Ratios

DE:TEV's free cash flow for Q2 2026 was $0.52. For the 2026 fiscal year, DE:TEV's free cash flow was decreased by $ and operating cash flow was $-0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.88 1.04 0.98 1.02 1.05
Quick Ratio
 0.67 0.80 0.75 0.69 0.72
Cash Ratio
 0.23 0.26 0.26 0.26 0.24
Solvency Ratio
 0.05 0.07 -0.02 0.02 -0.03
Operating Cash Flow Ratio
 0.19 0.12 0.10 0.11 0.14
Short-Term Operating Cash Flow Coverage
 0.66 0.91 0.70 0.82 0.75
Net Current Asset Value
$ -18.34B$ -18.89B$ -21.05B$ -22.87B$ -23.36B
Leverage Ratios
Debt-to-Assets Ratio
 0.42 0.43 0.46 0.46 0.49
Debt-to-Equity Ratio
 2.16 2.20 3.36 2.68 2.76
Debt-to-Capital Ratio
 0.68 0.69 0.77 0.73 0.73
Long-Term Debt-to-Capital Ratio
 0.61 0.66 0.75 0.71 0.71
Financial Leverage Ratio
 5.14 5.15 7.32 5.79 5.64
Debt Service Coverage Ratio
 0.58 1.21 1.38 0.58 -0.09
Interest Coverage Ratio
 2.99 2.35 -0.32 0.42 -2.36
Debt to Market Cap
 0.39 0.48 0.71 1.70 2.10
Interest Debt Per Share
 15.13 15.92 16.82 18.93 20.26
Net Debt to EBITDA
 4.26 4.40 3.34 10.86 -20.28
Profitability Margins
Gross Profit Margin
52.46%51.79%48.74%48.25%46.72%
EBIT Margin
12.00%12.39%20.38%2.56%-14.96%
EBITDA Margin
17.71%18.20%26.78%9.83%-6.20%
Operating Profit Margin
14.92%12.50%-1.83%2.73%-14.72%
Pretax Profit Margin
4.15%7.17%-7.76%-3.93%-21.05%
Net Profit Margin
4.12%8.17%-9.91%-3.53%-16.39%
Continuous Operations Profit Margin
4.13%8.22%-11.84%-3.88%-16.74%
Net Income Per EBT
99.20%113.89%127.75%89.87%77.85%
EBT Per EBIT
27.83%57.39%423.43%-143.65%143.01%
Return on Assets (ROA)
1.80%3.46%-4.17%-1.29%-5.56%
Return on Equity (ROE)
9.18%17.83%-30.50%-7.45%-31.34%
Return on Capital Employed (ROCE)
10.73%7.90%-1.14%1.39%-6.75%
Return on Invested Capital (ROIC)
9.00%7.41%-1.07%1.30%-5.04%
Return on Tangible Assets
3.46%6.72%-8.29%-2.67%-12.16%
Earnings Yield
1.67%3.93%-6.58%-4.78%-24.16%
Efficiency Ratios
Receivables Turnover
 5.02 4.65 5.41 4.65 4.04
Payables Turnover
 3.07 3.29 3.85 3.15 4.21
Inventory Turnover
 2.59 2.62 2.82 2.04 2.07
Fixed Asset Turnover
 4.11 3.90 3.34 2.58 2.42
Asset Turnover
 0.44 0.42 0.42 0.36 0.34
Working Capital Turnover Ratio
 -20.40 140.30 -5.51K 38.65 14.03
Cash Conversion Cycle
 94.65 106.87 102.09 141.67 179.71
Days of Sales Outstanding
 72.77 78.45 67.49 78.51 90.39
Days of Inventory Outstanding
 140.90 139.46 129.41 178.98 175.94
Days of Payables Outstanding
 119.03 111.03 94.81 115.82 86.61
Operating Cycle
 213.67 217.91 196.90 257.49 266.32
Cash Flow Ratios
Operating Cash Flow Per Share
 2.52 1.44 1.10 1.22 1.43
Free Cash Flow Per Share
 2.04 1.00 0.66 0.75 0.94
CapEx Per Share
 0.47 0.44 0.44 0.47 0.49
Free Cash Flow to Operating Cash Flow
 0.81 0.70 0.60 0.62 0.66
Dividend Paid and CapEx Coverage Ratio
 5.32 3.29 2.50 2.60 2.90
Capital Expenditure Coverage Ratio
 5.32 3.29 2.50 2.60 2.90
Operating Cash Flow Coverage Ratio
 0.18 0.09 0.07 0.07 0.07
Operating Cash Flow to Sales Ratio
 0.17 0.10 0.08 0.09 0.11
Free Cash Flow Yield
5.55%3.20%3.00%7.21%10.29%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 58.47 25.37 -15.20 -20.90 -4.14
Price-to-Sales (P/S) Ratio
 2.47 2.08 1.51 0.74 0.68
Price-to-Book (P/B) Ratio
 5.53 4.53 4.64 1.56 1.30
Price-to-Free Cash Flow (P/FCF) Ratio
 18.01 31.24 33.28 13.87 9.72
Price-to-Operating Cash Flow Ratio
 14.63 21.75 19.99 8.54 6.37
Price-to-Earnings Growth (PEG) Ratio
 0.11 -0.14 -0.08 0.27 <0.01
Price-to-Fair Value
 5.53 4.53 4.64 1.56 1.30
Enterprise Value Multiple
 18.18 15.82 8.96 18.36 -31.23
Enterprise Value
 56.01B 49.69B 39.71B 28.61B 28.88B
EV to EBITDA
 18.18 15.82 8.96 18.36 -31.23
EV to Sales
 3.22 2.88 2.40 1.81 1.94
EV to Free Cash Flow
 23.52 43.28 53.01 33.98 27.72
EV to Operating Cash Flow
 19.10 30.13 31.84 20.91 18.17
Tangible Book Value Per Share
 -9.79 -10.33 -12.24 -12.90 -13.79
Shareholders’ Equity Per Share
 6.65 6.88 4.75 6.71 7.03
Tax and Other Ratios
Effective Tax Rate
 <0.01 -0.15 -0.53 0.01 0.20
Revenue Per Share
 14.94 15.02 14.63 14.16 13.45
Net Income Per Share
 0.62 1.23 -1.45 -0.50 -2.20
Tax Burden
 0.99 1.14 1.28 0.90 0.78
Interest Burden
 0.35 0.58 -0.38 -1.54 1.41
Research & Development to Revenue
 0.10 0.06 0.06 0.06 0.06
SG&A to Revenue
 0.24 0.23 0.22 0.07 0.08
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 4.04 1.16 -0.64 -2.22 -0.66
Currency in USD